Series 12 Won't Save Apple's Slowing Wearables Segment
Apple's latest smartwatch, the Series 12, is now available for preorder at $399 in the US and will hit stores on September 18. The price remains unchanged from last year's model, meaning that Apple won't be able to rely on a price hike to drive sales.
The new watch boasts a more active health sensor, which can measure heart rate every five seconds during the day and sample heart-rate variability as often as every five minutes. This supports a new Readiness score, while also offering up to 10 hours of outdoor-workout battery life, 25% more than its predecessor.
However, Apple's own numbers suggest that the wearables segment is still relatively small, accounting for only 7.2% of quarterly sales and just 1.2% of year-over-year dollar growth in the first nine months of fiscal 2026. The success of the Series 12 will therefore depend on whether its health features can persuade existing owners to upgrade their devices.
Analysts are skeptical that a single product can significantly impact Apple's overall growth, and instead point to the company's ecosystem value as a more persuasive upside case. A compelling health upgrade could keep iPhone owners locked into the Apple hardware-and-services loop, supporting accessory sales and deeper use of health and fitness software.
The first test for the Series 12 will be preorder availability and delivery times across major configurations, but the cleaner financial test comes later: Wearables, Home and Accessories needs to accelerate from its 2% nine-month growth rate without sacrificing companywide margin. If category growth remains in the low single digits through the holiday period, the Series 12 will look more like a useful retention product than a material new engine for Apple.